Login

Exploring the Future of Finance with Hanwha Life CEO | Kim Dong Kwan - CEO of Hanwha Corp 00:10:00

Share On Facebook Share On Twitter

Kim Dong Kwan is the CEO of Hanwha Corp

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
"Mastering Investment Decisions in 2024: Insights with Caspar Berry | Schroders Investor Download Podcast"
00:10:00
Geoffrey Benic, CEO of Aleafia Health Inc., and Louis Laflamme, CEO of Opsens Inc., share insights in "The View From The C-Suite."
00:10:00
Thinkific Labs Inc., a publicly traded company on the TSX , owns the trademark Thinkific.
00:10:00
Support the next-rising technologies, products, and services that delight consumers|Richard Jun,Managing Partner,BAM Ventures
00:10:00
Insights into Lithium Demand and Domestic Production: An Interview with Dr. Bill Willoughby of Cypress Development Corp
00:10:00
Group CEO of Córas Iompair Éireann (CIE), Bruce Heppenstall, and Plant Director of Drax Group plc, David Johnson, discuss collaborative initiatives in energy and security.
00:10:00
Unbundling The Fintech Opportunity|Marc Andrusko,Partner,Andreessen Horowitz
00:10:00
A Construction Company's Innovative Approach to Environmental Responsibility and Waste Management | Leandro Melnick , CEO,Even Construtora e Incorporadora SA.
00:10:00
An exclusive event connecting mining company management teams with institutional investors for investor meetings and market intelligence gathering in Hong Kong.|Barry Cahill Managing Director of Finders Resources
00:00:00
Destiny Pharma's nasal spray project already delivering "more than hoped for" - Neil Clark , CEO, Destiny Pharma
00:10:00
Balancing the Vital Role of Semiconductors with Climate Challenges: Insights from Joshua French | Joshua French - Global Equity Analyst at Aviva Investors
00:10:00
Insights from Shemara's Three-Decade Journey at Macquarie Group |Shemara Wikramanayake , CEO, Macquarie Group.

© 2026 Nehu